ClinicalTrials.govpublic full text
Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation
hepatocellular carcinoma, liver transplantation, recurrent hepatocellular carcinoma, relenvatinib, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 863089
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.